Related Experiment Video
Updated: Aug 15, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
c-myc expression: keep the noise down!
1Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892-1500, USA.
Abstract:
The c-myc proto-oncogene encodes a nuclear protein that is deregulated and/or mutated in most human cancers. Acting primarily as an activator and sometimes as a repressor, MYC protein controls the synthesis of up to 10-15% of genes. The key MYC targets contributing to oncogenesis are incompletely enumerated and it is not known whether pathology arises from the expression of physiologic targets at abnormal levels or from the pathologic response of new target genes that are not normally regulated by MYC. Regardless of which, available evidence indicates that the level of MYC expression is an important determinant of MYC biology. The c-myc promoter has architectural and functional features that contribute to uniform expression and help to prevent or mitigate conditions that might otherwise create noisy expression. Those features include the use of an expanded proximal promoter, the averaging of input from dozens of transcription factors, and real-time feedback using the supercoil-deformable Far UpStream Element (FUSE) as physical sensor of ongoing transcriptional activity, and the FUSE binding protein (FBP) as well as the FBP interacting repressor (FIR) as effectors to enforce normal transcription from the c-myc promoter.
Insights
The MYC protein, crucial in cancer, regulates many genes. Its promoter has unique features, including the FUSE element and regulatory proteins, ensuring stable expression and preventing abnormal activity.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- The c-myc proto-oncogene encodes MYC, a nuclear protein frequently deregulated in human cancers.
- MYC protein regulates 10-15% of genes, acting as both an activator and repressor.
- The precise MYC targets driving oncogenesis and the role of aberrant expression levels versus new targets remain unclear.
Purpose of the Study:
- To investigate the regulatory mechanisms of the c-myc promoter that ensure uniform expression.
- To understand how promoter architecture prevents or mitigates transcriptional noise.
- To elucidate the roles of the Far UpStream Element (FUSE) and its associated proteins (FBP, FIR) in c-myc regulation.
Main Methods:
- Analysis of c-myc promoter structure and function.
- Investigation of transcription factor interactions and feedback mechanisms.
- Characterization of the roles of FUSE, FBP, and FIR in regulating c-myc transcription.
Main Results:
- The c-myc promoter possesses architectural features promoting uniform expression.
- These features include an expanded proximal promoter and averaging of multiple transcription factor inputs.
- Real-time transcriptional feedback is mediated by the FUSE element and its binding proteins (FBP, FIR).
Conclusions:
- The c-myc promoter has evolved sophisticated mechanisms to maintain stable expression levels.
- These mechanisms involve promoter architecture, combinatorial transcription factor control, and dynamic feedback loops.
- The FUSE-FBP-FIR pathway is critical for enforcing normal transcription and preventing aberrant MYC activity, thereby impacting cancer development.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Circadian Rhythms and Gene Regulation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

